These EVs showed a significant antitumor activity against glioblastoma, with 89.8% apoptosis of the glioblastoma cells, as compared with the 20.4% apoptosis when the cancer cells were treated with FasL inhibitors [3]. This evidence concerns the gene FASLG and glioblastoma.